Pea3 transcription factors and wnt1-induced mouse mammary neoplasia

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Baker, Rebecca ^a,b   Kent, Claire V ^a   Silbermann, Rachel A ^a,b   Hassell, John A ^c   Young, Lawrence J T ^d   Howe, Louise R ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR PEA3; WNT1 PROTEIN; PRIMER DNA; TRANSCRIPTION FACTOR; WNT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST TUMOR; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PROTEIN EXPRESSION; TRANSGENE; ANIMAL; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; BASE SEQUENCE; BETA CATENIN; DNA PRIMERS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSGENES; WNT1 PROTEIN;

EID: 77749309897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008854     Document Type: Article

References (96)

1. Graves BJ, Petersen JM (1998) Specificity within the ets family of transcription factors. Adv Cancer Res 75: 1-55.
2. Sharrocks AD (2001) The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2: 827-837.
3. Shepherd T, Hassell JA (2001) Role of Ets transcription factors in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia 6: 129-140.
4. Martin ME, Piette J, Yaniv M, Tang WJ, Folk WR (1988) Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A 85: 5839-5843.
5. Wasylyk C, Flores P, Gutman A, Wasylyk B (1989) PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. Embo J 8: 3371-3378.
6. Higashino F, Yoshida K, Fujinaga Y, Kamio K, Fujinaga K (1993) Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: a new human member of the ets oncogene family. Nucleic Acids Res 21: 547-553.
7. Xin JH, Cowie A, Lachance P, Hassell JA (1992) Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev 6: 481-496.
8. Bojovic BB, Hassell JA (2001) The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding. J Biol Chem 276: 4509-4521.
9. Greenall A, Willingham N, Cheung E, Boam DS, Sharrocks AD (2001) DNA binding by the ETS-domain transcription factor PEA3 is regulated by intramolecular and intermolecular protein.protein interactions. J Biol Chem 276: 16207-16215.
10. Monte D, Baert JL, Defossez PA, de Launoit Y, Stehelin D (1994) Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene 9: 1397-1406.
11. Monte D, Coutte L, Baert JL, Angeli I, Stehelin D, et al. (1995) Molecular characterization of the ets-related human transcription factor ER81. Oncogene 11: 771-779.
12. Monte D, Coutte L, Dewitte F, Defossez PA, Le Coniat M, et al. (1996) Genomic organization of the human ERM (ETV5) gene, a PEA3 group member of ETS transcription factors. Genomics 35: 236-240.
13. Bojovic BB, Hassell JA (2008) The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation. DNA Cell Biol 27: 289-305.
14. Nishida T, Terashima M, Fukami K, Yamada Y (2007) Repression of E1AF transcriptional activity by sumoylation and PIASy. Biochem Biophys Res Commun 360: 226-232.
15. Guo B, Sallis RE, Greenall A, Petit MM, Jansen E, et al. (2006) The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3. Mol Cell Biol 26: 4529-4538.
16. Firlej V, Bocquet B, Desbiens X, de Launoit Y, Chotteau-Lelievre A (2005) Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. J Biol Chem 280: 887-898.
17. de Launoit Y, Baert JL, Chotteau A, Monte D, Defossez PA, et al. (1997) Structure-function relationships of the PEA3 group of Ets-related transcription factors. Biochem Mol Med 61: 127-135.
18. Lynch CC, Crawford HC, Matrisian LM, McDonnell S (2004) Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. Int J Oncol 24: 1565-1572.
19. Arber S, Ladle DR, Lin JH, Frank E, Jessell TM (2000) ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons. Cell 101: 485-498.
20. Chotteau-Lelievre A, Desbiens X, Pelczar H, Defossez PA, de Launoit Y (1997) Differential expression patterns of the PEA3 group transcription factors through murine embryonic development. Oncogene 15: 937-952.
21. Chotteau-Lelievre A, Dolle P, Peronne V, Coutte L, de Launoit Y, et al. (2001) Expression patterns of the Ets transcription factors from the PEA3 group during early stages of mouse development. Mech Dev 108: 191-195.
22. Chotteau-Lelievre A, Montesano R, Soriano J, Soulie P, Desbiens X, et al. (2003) PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev Biol 259: 241-257.
23. Ladle DR, Frank E (2002) The role of the ETS gene PEA3 in the development of motor and sensory neurons. Physiol Behav 77: 571-576.
24. Lin JH, Saito T, Anderson DJ, Lance-Jones C, Jessell TM, et al. (1998) Functionally related motor neuron pool and muscle sensory afferent subtypes defined by coordinate ETS gene expression. Cell 95: 393-407.
25. Liu Y, Jiang H, Crawford HC, Hogan BL (2003) Role for ETS domain transcription factors Pea3/Erm in mouse lung development. Dev Biol 261: 10-24.
26. Livet J, Sigrist M, Stroebel S, De Paola V, Price SR, et al. (2002) ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools. Neuron 35: 877-892.
27. Laing MA, Coonrod S, Hinton BT, Downie JW, Tozer R, et al. (2000) Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene. Mol Cell Biol 20: 9337-9345.
28. Baert JL, Monte D, Musgrove EA, Albagli O, Sutherland RL, et al. (1997) Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int J Cancer 70: 590-597.
29. Barrett JM, Puglia MA, Singh G, Tozer RG (2002) Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat 72: 227-232.
30. Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279: 11281-11292.
31. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, et al. (2001) PEA3 is upregulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276: 20108-20115.
32. Shepherd TG, Kockeritz L, Szrajber MR, Muller WJ, Hassell JA (2001) The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr Biol 11: 1739-1748.
33. Trimble MS, Xin JH, Guy CT, Muller WJ, Hassell JA (1993) PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene 8: 3037-3042.
34. Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D, et al. (1994) Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J Biol Chem 269: 19848-19858.
35. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, et al. (1997) HER2/ Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15: 1513-1525.
36. Bieche I, Tozlu S, Girault I, Onody P, Driouch K, et al. (2004) Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression. Carcinogenesis 25: 405-411.
37. Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, et al. (2004) Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol 57: 1069-1074.
38. Kinoshita J, Kitamura K, Tanaka S, Sugimachi K, Ishida M, et al. (2002) Clinical significance of PEA3 in human breast cancer. Surgery 131: S222-225.
39. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, et al. (2006) A positive role for PEA3 in HER2-mediated breast tumour progression. Br J Cancer 95: 1404-1409.
40. Xia WY, Lien HC, Wang SC, Pan Y, Sahin A, et al. (2006) Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer. Breast Cancer Res Treat 98: 295-301.
41. Boedefeld WM II, Soong R, Weiss H, Diasio RB, Urist MM, et al. (2005) E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7. Mol Carcinog 43: 13-17.
42. Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, et al. (2001) The PEA3 subfamily of Ets transcription factors synergizes with ßcatenin/ LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21: 1370-1383.
43. Hiroumi H, Dosaka-Akita H, Yoshida K, Shindoh M, Ohbuchi T, et al. (2001) Expression of E1AF/PEA3, an Ets-related transcription factor in human nonsmall-cell lung cancers: its relevance in cell motility and invasion. Int J Cancer 93: 786-791.
44. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, et al. (2003) Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 200: 568-576.
45. Nosho K, Yoshida M, Yamamoto H, Taniguchi H, Adachi Y, et al. (2005) Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Carcinogenesis 26: 892-899.
46. Yamamoto H, Horiuchi S, Adachi Y, Taniguchi H, Nosho K, et al. (2004) Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. Carcinogenesis 25: 325-332.
47. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, et al. (2003) PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Clin Cancer Res 9: 1412-1419.
48. Firlej V, Ladam F, Brysbaert G, Dumont P, Fuks F, et al. (2008) Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription. J Cell Sci 121: 3393-3402.
49. Buttice G, Kurkinen M (1993) A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13- acetate response of the human stromelysin gene. J Biol Chem 268: 7196-7204.
50. Crawford HC, Matrisian LM (1996) Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49: 20-37.
51. Chen JH, Vercamer C, Li Z, Paulin D, Vandenbunder B, et al. (1996) PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene 13: 1667-1675.
52. Discenza MT, Vaz D, Hassell JA, Pelletier J (2004) Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett 560: 183-191.
53. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC (2004) Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279: 20794-20806.
54. Hesselbrock DR, Kurpios N, Hassell JA, Watson MA, Fleming TP (2005) PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin. Breast Cancer Res Treat 89: 289-296.
55. Howe LR, Watanabe O, Leonard J, Brown AMC (2003) Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 63: 1906-1913.
56. Jiang J, Wei Y, Liu D, Zhou J, Shen J, et al. (2007) E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. Biochem Biophys Res Commun 358: 53-58.
57. Matsui K, Sugimori K, Motomura H, Ejiri N, Tsukada K, et al. (2006) PEA3 cooperates with c-Jun in regulation of HER2/neu transcription. Oncol Rep 16: 153-158.
58. Perez A, Barco R, Fernandez I, Price-Schiavi SA, Carraway KL (2003) PEA3 transactivates the Muc4/sialomucin complex promoter in mammary epithelial and tumor cells. J Biol Chem 278: 36942-36952.
59. Rorth P, Nerlov C, Blasi F, Johnsen M (1990) Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res 18: 5009-5017.
60. Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, et al. (2000) Ets regulation of the erbB2 promoter. Oncogene 19: 6490-6502.
61. D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, et al. (1997) Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201: 179-187.
62. Upadhyay S, Liu C, Chatterjee A, Hoque MO, Kim MS, et al. (2006) LKB1/ STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res 66: 7870-7879.
63. Cowden Dahl KD, Dahl R, Kruichak JN, Hudson LG (2009) The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11: 1208-1215.
64. Wang SC, Hung MC (2000) Transcriptional targeting of the HER-2/neu oncogene. Drugs Today (Barc) 36: 835-843.
65. Wang SC, Hung MC (2001) HER2 overexpression and cancer targeting. Semin Oncol 28: 115-124.
66. Xing X, Wang SC, Xia W, Zou Y, Shao R, et al. (2000) The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med 6: 189-195.
67. Yu Z, Xia W, Wang HY, Wang SC, Pan Y, et al. (2006) Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1. Mol Carcinog 45: 667-675.
68. Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, et al. (2004) E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Exp Cell Res 299: 525-532.
69. Menendez JA, Lupu R (2006) Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol 7: 495-502.
70. Kurpios NA, MacNeil L, Shepherd TG, Gludish DW, Giacomelli AO, et al. (2009) The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev Biol 325: 106-121.
71. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
72. Robinson GW, McKnight RA, Smith GH, Hennighausen L (1995) Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079-2090.
73. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, et al. (2002) Wnt/betacatenin/ Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
74. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, et al. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-1193.
75. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, et al. (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891.
76. Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, et al. (2005) HER2/neuinduced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res 65: 10113-10119.
77. Cui XS, Donehower LA (2000) Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Oncogene 19: 5988-5996.
78. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, et al. (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 100: 15853-15858.
79. Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, et al. (2002) Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 161: 1087-1097.
80. Teissedre B, Pinderhughes A, Incassati A, Hatsell SJ, Hiremath M, et al. (2009) MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS ONE 4: e4537.
81. Span PN, Manders P, Heuvel JJ, Beex LV, Sweep CG (2003) E1AF expression levels are not associated with prognosis in human breast cancer. Breast Cancer Res Treat 79: 129-131.
82. Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, et al. (2002) Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 62: 5405-5407.
83. Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S, et al. (1996) A single etsrelated transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 12: 221-227.
84. Hida K, Shindoh M, Yasuda M, Hanzawa M, Funaoka K, et al. (1997) Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am J Pathol 150: 2125-2132.
85. Lindvall C, Evans NC, Zylstra CR, Li Y, Alexander CM, et al. (2006) The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem 281: 35081-35087.
86. Liu BY, McDermott SP, Khwaja SS, Alexander CM (2004) The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 101: 4158-4163.
87. Prestwich TC, Macdougald OA (2007) Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19: 612-617.
88. Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, et al. (2009) The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS ONE 4: e5813.
89. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, et al. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26: 364-371.
90. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76.
91. Anders C, Carey LA (2008) Understanding and treating triple-negative breast cancer. Oncology (Williston Park) 22: 1233-1239; discussion 1239-1240, 1243.
92. Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8: 235-244.
93. Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52: 108-118.
94. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
95. Stingl J (2009) Detection and analysis of mammary gland stem cells. J Pathol 217: 229-241.
96. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007.